• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LEGN

LEGN

Legend Biotech Corporation

NASDAQHealthcareBiotechnologyUS

USD35.98

-0.30 (-0.83%)

Rating:C-

Company Profile

CEO

Ying Huang

IPO Date

2020-06-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$34.98

Prev. Close

$36.28

Day Low

$34.35

Day High

$37.45

52W Low

$16.24

52W High

$45.30

Market Cap

$6.65B

Volume

4.08M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

44.8%

Avg Negative

1.8%

Avg Neutral

53.6%

News Feed

Moving Average Crossover Alert: Legend Biotech (LEGN)

Zacks Investment Research·6/4/2021·↑ positive

LEGN Stock Price: Over 7% Increase Pre-Market Explanation

Pulse2·6/1/2021·↑ positive

U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma

Business Wire·5/26/2021·↑ positive

Legend Biotech to Present at the Jefferies Virtual Healthcare Conference

Business Wire·5/25/2021·↑ positive

Are Options Traders Betting on a Big Move in Legend Biotech (LEGN) Stock?

Zacks Investment Research·5/20/2021·↑ positive

Legend Biotech (LEGN) Stock: Over 10% Increase Explanation

Pulse2·5/18/2021·↑ positive

Legend Biotech (LEGN) Stock: Over 10% Increase Pre-Market Explanation

Pulse2·5/14/2021·↑ positive

Legend Biotech Reports New and Updated Data from BCMA CAR-T Program at 2021 ASCO and EHA Meetings

Business Wire·5/12/2021·↑ positive

Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Business Wire·4/30/2021·↑ positive

Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/18/2021·↑ positive